Mechanisms Underlying the Antifibrotic Potential of Estradiol for Vocal Fold Fibrosis
- 30 December 2020
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 131 (10) , 2285-2291
Abstract
Objectives/Hypothesis Vocal fold fibrosis remains a significant clinical challenge. Estrogens, steroid hormones predominantly responsible for secondary sexual characteristics in women, have been shown to alter wound healing and limit fibrosis, but the effects on vocal fold fibrosis are unknown. We sought to elucidate the expression of estrogen receptors and the effects of estrogens on TGF‐β1 signaling in rat vocal fold fibroblasts (VFFs). Study Design In vitro. Methods VFFs were isolated from 10‐week‐old, male Sprague–Dawley rats, and estrogen receptor alpha (ERα) and G protein‐coupled receptor 30 (GPR30) were examined via immunostaining and quantitative polymerase chain reaction (qPCR). VFFs were treated with estradiol (E2, 10−7, 10−8 or 10−9 M) ± transforming growth factor beta 1 (TGF‐β1, 10 ng/mL). ICI 182,780 (ICI, 10−7 M) or G36 (10−7 M) were employed as antagonists of ERα or GPR30, respectively. qPCR was employed to determine estrogen receptor‐mediated effects of E2 on genes related to fibrosis. Results ERα and GPR30 were expressed in VFFs at both the protein and the mRNA levels. E2 (10−7 M) did not alter Smad3, Smad7, Acta2 mRNA, or extracellular matrix related genes. However, the combination of E2 (10−8 M) and TGF‐β1 significantly increased Smad7 (P = .03) and decreased Col1a1 (P = .04) compared to TGF‐β1 alone; this response was negated by the combination of ICI and G36 (P = .009). Conclusions E2 regulated TGF‐β1/Smad signaling via estrogen receptors in VFFs. These findings provide insight into potential mechanisms of estrogens on vocal fold injury with the goal of enhanced therapeutics for vocal fold fibrosis. Level of Evidence NA Laryngoscope, 2021Keywords
This publication has 45 references indexed in Scilit:
- The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusionBMC Neuroscience, 2013
- Voice and Speech Changes in Various Phases of Menstrual CycleJournal of Voice, 2013
- Role of Smads in TGFβ signalingCell and tissue research, 2011
- Estradiol Inhibits Depolarization-Evoked Exocytosis in PC12 Cells via N-Type Voltage-Gated Calcium ChannelsCellular and Molecular Neurobiology, 2010
- 17β-Estradiol Inhibits Wound Healing in Male Mice via Estrogen Receptor-αThe American Journal of Pathology, 2010
- A Rat Excised Larynx Model of Vocal Fold ScarJournal of Speech, Language, and Hearing Research, 2009
- 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signalingAmerican Journal of Physiology-Renal Physiology, 2007
- Topical Estrogen Accelerates Cutaneous Wound Healing in Aged Humans Associated with an Altered Inflammatory ResponseThe American Journal of Pathology, 1999
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996